Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma.
Immunotherapy. 2021 Apr;13(5):397-407. doi: 10.2217/imt-2020-0263. Epub 2021 Feb 9.
Immunotherapy. 2021.
PMID: 33557591
Free PMC article.
Phase II/III trial of hyperimmune anti-COVID-19 intravenous immunoglobulin (C-IVIG) therapy in severe COVID-19 patients: study protocol for a randomized controlled trial.
Ali S, Shalim E, Farhan F, Anjum F, Ali A, Uddin SM, Shahab F, Haider M, Ahmed I, Ali MR, Khan S, Rao S, Guriro K, Elahi S, Ali M, Mushtaq T, Sayeed MA, Muhaymin SM, Luxmi S, Saifullah, Qureshi S.
Ali S, et al. Among authors: ahmed i.
Trials. 2022 Nov 8;23(1):932. doi: 10.1186/s13063-022-06860-2.
Trials. 2022.
PMID: 36348476
Free PMC article.
Item in Clipboard
Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial.
Ali S, Uddin SM, Shalim E, Sayeed MA, Anjum F, Saleem F, Muhaymin SM, Ali A, Ali MR, Ahmed I, Mushtaq T, Khan S, Shahab F, Luxmi S, Kumar S, Arain H, Khan M, Khan AS, Mehmood H, Rasheed A, Jahangeer A, Baig S, Quraishy S.
Ali S, et al. Among authors: ahmed i.
EClinicalMedicine. 2021 Jun;36:100926. doi: 10.1016/j.eclinm.2021.100926. Epub 2021 Jun 4.
EClinicalMedicine. 2021.
PMID: 34109306
Free PMC article.
Item in Clipboard
Probiotic potential of Saccharomyces strains isolated from Litchi chinensis (Lychee fruit).
Khan M, Ahmed I, Farooq S, Khan S, Amin R, Ali S.
Khan M, et al. Among authors: ahmed i.
Pak J Pharm Sci. 2020 Jul;33(4(Supplementary)):1855-1861.
Pak J Pharm Sci. 2020.
PMID: 33612470
Item in Clipboard
Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.
Ali S, Luxmi S, Anjum F, Muhaymin SM, Uddin SM, Ali A, Ali MR, Tauheed S, Khan M, Bajwa M, Baig SU, Shalim E, Ahmed I, Khan AS, Quraishy S.
Ali S, et al. Among authors: ahmed i.
Trials. 2020 Nov 2;21(1):905. doi: 10.1186/s13063-020-04839-5.
Trials. 2020.
PMID: 33138867
Free PMC article.
Item in Clipboard
Cite
Cite